Gp Act Iii Acquisition Stock Today

GPAT Stock   10.28  0.01  0.1%   

Performance

Modest

 
Weak
 
Strong

Odds Of Distress

Quite High

 
High
 
Low
GP Act is selling for under 10.28 as of the 21st of March 2025; that is 0.1 percent increase since the beginning of the trading day. The stock's last reported lowest price was 10.28. GP Act has more than 65 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.

Moving together with GPAT Stock

  0.66DX Dynex CapitalPairCorr
  0.62LU Lufax Holding Downward RallyPairCorr

Moving against GPAT Stock

  0.38MC MoelisPairCorr
  0.36SF Stifel FinancialPairCorr
  0.34RC Ready Capital CorpPairCorr
  0.32WD Walker DunlopPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

GPAT Stock Highlights

CEO DirectorAntonio Bonchristiano
Business ConcentrationDiversified Financial Services, Financial Services, Financials, Financial Services, Financial Services, Financial Services (View all Sectors)
GP Act III Acquisition (GPAT) is traded on NASDAQ Exchange in USA. It is located in 300 Park Avenue, New York, NY, United States, 10022 and employs 2 people. GP Act is listed under Diversified Financial Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 369.44 M. GP Act III conducts business under Financial Services sector and is part of Financials industry. The entity has 28.75 M outstanding shares of which 4.76 K shares are currently shorted by private and institutional investors with about 1.01 trading days to cover. GP Act generates negative cash flow from operations
Check GP Act Probability Of Bankruptcy
Ownership Allocation
GP Act III secures a total of 28.75 Million outstanding shares. The majority of GP Act III outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to purchase positions in GP Act III Acquisition to benefit from reduced commissions. Hence, outside corporations are subject to a different set of regulations than regular investors in GP Act III. Please pay attention to any change in the institutional holdings of GP Act as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check GPAT Ownership Details

GP Act III Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. GP Act market risk premium is the additional return an investor will receive from holding GP Act long position in a well-diversified portfolio.

GPAT Stock Against Markets

Additional Tools for GPAT Stock Analysis

When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.